Skip to main content

Table 2 The response and effects of neoadjuvant chemotherapy

From: A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis

Characteristic

Number of patients

Percent (%)

Response of Primary tumor

  

 CR

3

6.5

 PR

34

73.9

 SD

7

15.2

 PD

2

4.4

Response of PAL

  

 CR

8

17.4

 PR

27

58.7

 SD

9

19.6

 PD

2

4.4

Adverse Events (grade 3/4)

  

 Anemia

3

6.5

 Leukopenia

3

6.5

 Thrombocytopenia

2

4.3

 Hepatic inadequacy

0

0

 Renal dysfunction

0

0

 Nausea

6

13.0

 Vomiting

5

10.9

 Diarrhea

3

6.5

  1. CR complete response; PR partial response; SD stable disease; PD progressive disease